1. Academic Validation
  2. Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression

Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression

  • J Biol Chem. 2010 Apr 9;285(15):11297-307. doi: 10.1074/jbc.M109.068221.
Vladimir Majerciak 1 Michael Kruhlak Pradeep K Dagur J Philip McCoy Jr Zhi-Ming Zheng
Affiliations

Affiliation

  • 1 HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) ORF57 is a viral early protein essential for KSHV multiplication. We found that B cells derived from cavity-based B cell lymphoma with lytic KSHV Infection display activation of Caspase-8 and cleavage of ORF57 in the cytoplasm by caspase-7 at the aspartate residue at position 33 from the N terminus. Caspase-7 cleavage of ORF57 is prevented by pan-caspase inhibitor z-VAD, Caspase-3 and caspase-7 inhibitor z-DEVD, and caspase-7 small interfering RNAs. The caspase-7 cleavage site (30)DETD(33) in ORF57 is not cleavable by Caspase-3, although both enzymes use DEXD as a common cleavage site. B cells with lytic KSHV Infection and caspase-7 activation exhibited a greatly reduced level of ORF57. A majority of the cells expressing active caspase-7 appeared to have no detectable ORF57 and vice versa. Upon cleavage with caspase-7, ORF57 was deficient in promoting the expression of viral lytic genes. Inhibiting caspase-7 cleavage of ORF57 in KSHV(+) BCBL-1 cells by z-VAD, z-DEVD, or caspase-7 small interfering RNA led to increased expression of viral lytic genes and production of cell-free virus particles. Collectively, our data provide the first compelling evidence that Caspase cleavage of ORF57 may represent a cellular function against lytic KSHV Infection.

Figures